123 related articles for article (PubMed ID: 33527196)
21. CCR8 marks highly suppressive Treg cells within tumours but is dispensable for their accumulation and suppressive function.
Whiteside SK; Grant FM; Gyori DS; Conti AG; Imianowski CJ; Kuo P; Nasrallah R; Sadiyah F; Lira SA; Tacke F; Eil RL; Burton OT; Dooley J; Liston A; Okkenhaug K; Yang J; Roychoudhuri R
Immunology; 2021 Aug; 163(4):512-520. PubMed ID: 33838058
[TBL] [Abstract][Full Text] [Related]
22. Single-cell chromatin accessibility landscape identifies tissue repair program in human regulatory T cells.
Delacher M; Simon M; Sanderink L; Hotz-Wagenblatt A; Wuttke M; Schambeck K; Schmidleithner L; Bittner S; Pant A; Ritter U; Hehlgans T; Riegel D; Schneider V; Groeber-Becker FK; Eigenberger A; Gebhard C; Strieder N; Fischer A; Rehli M; Hoffmann P; Edinger M; Strowig T; Huehn J; Schmidl C; Werner JM; Prantl L; Brors B; Imbusch CD; Feuerer M
Immunity; 2021 Apr; 54(4):702-720.e17. PubMed ID: 33789089
[TBL] [Abstract][Full Text] [Related]
23. In vivo cisplatin-resistant neuroblastoma metastatic model reveals tumour necrosis factor receptor superfamily member 4 (TNFRSF4) as an independent prognostic factor of survival in neuroblastoma.
Murphy C; Devis-Jauregui L; Struck R; Boloix A; Gallagher C; Gavin C; Cottone F; Fernandez AS; Madden S; Roma J; Segura MF; Piskareva O
PLoS One; 2024; 19(5):e0303643. PubMed ID: 38809883
[TBL] [Abstract][Full Text] [Related]
24. Potential anti-tumor effects of regulatory T cells in the tumor microenvironment: a review.
Li Y; Zhang C; Jiang A; Lin A; Liu Z; Cheng X; Wang W; Cheng Q; Zhang J; Wei T; Luo P
J Transl Med; 2024 Mar; 22(1):293. PubMed ID: 38509593
[TBL] [Abstract][Full Text] [Related]
25. Identification of necroptosis-related lncRNAs for prognosis prediction and screening of potential drugs in patients with colorectal cancer.
Chen ZH; Lin YL; Chen SQ; Yang XY
World J Gastrointest Oncol; 2023 Nov; 15(11):1951-1973. PubMed ID: 38077636
[TBL] [Abstract][Full Text] [Related]
26. Biomarkers and experimental models for cancer immunology investigation.
Xu H; Jia Z; Liu F; Li J; Huang Y; Jiang Y; Pu P; Shang T; Tang P; Zhou Y; Yang Y; Su J; Liu J
MedComm (2020); 2023 Dec; 4(6):e437. PubMed ID: 38045830
[TBL] [Abstract][Full Text] [Related]
27. Integrated BATF transcriptional network regulates suppressive intratumoral regulatory T cells.
Shan F; Cillo AR; Cardello C; Yuan DY; Kunning SR; Cui J; Lampenfeld C; Williams AM; McDonough AP; Pennathur A; Luketich JD; Kirkwood JM; Ferris RL; Bruno TC; Workman CJ; Benos PV; Vignali DAA
Sci Immunol; 2023 Sep; 8(87):eadf6717. PubMed ID: 37713508
[TBL] [Abstract][Full Text] [Related]
28. m5C regulator-mediated methylation modification phenotypes characterized by distinct tumor microenvironment immune heterogenicity in colorectal cancer.
Chen Z; Li Q; Lin Y; Lin S; Gao J; Chen S
Sci Rep; 2023 Jul; 13(1):11950. PubMed ID: 37488178
[TBL] [Abstract][Full Text] [Related]
29. Immune Response and Immune Checkpoint Molecules in Patients with Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy: A Review.
Koukourakis IM; Platoni K; Tiniakos D; Kouloulias V; Zygogianni A
Curr Issues Mol Biol; 2023 May; 45(5):4495-4517. PubMed ID: 37232754
[TBL] [Abstract][Full Text] [Related]
30. Clinical significance and changes to the immune microenvironment of colorectal cancer patients with liver metastasis.
Wang T; Tang L; Ouyang B; Chen X; Qi J
J Gastrointest Oncol; 2023 Feb; 14(1):206-212. PubMed ID: 36915466
[TBL] [Abstract][Full Text] [Related]
31. In or out of control: Modulating regulatory T cell homeostasis and function with immune checkpoint pathways.
Abdeladhim M; Karnell JL; Rieder SA
Front Immunol; 2022; 13():1033705. PubMed ID: 36591244
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic targeting of regulatory T cells in cancer.
Shan F; Somasundaram A; Bruno TC; Workman CJ; Vignali DAA
Trends Cancer; 2022 Nov; 8(11):944-961. PubMed ID: 35853825
[TBL] [Abstract][Full Text] [Related]
33. Different subpopulations of regulatory T cells in human autoimmune disease, transplantation, and tumor immunity.
Jiang Z; Zhu H; Wang P; Que W; Zhong L; Li XK; Du F
MedComm (2020); 2022 Jun; 3(2):e137. PubMed ID: 35474948
[TBL] [Abstract][Full Text] [Related]
34. Negative Regulation of the IL-1 System by IL-1R2 and IL-1R8: Relevance in Pathophysiology and Disease.
Supino D; Minute L; Mariancini A; Riva F; Magrini E; Garlanda C
Front Immunol; 2022; 13():804641. PubMed ID: 35211118
[TBL] [Abstract][Full Text] [Related]
35. CD30
Lam JH; Hong M; Koo SL; Chua CWL; Lim KL; Wee F; Wan WK; Leow WQ; Yeo JG; Tan IBH; Yeong J; Lim TKH; Lim TS
Cancer Immunol Immunother; 2021 Aug; 70(8):2353-2365. PubMed ID: 33527196
[TBL] [Abstract][Full Text] [Related]
36. The survival of memory CD4+ T cells within the gut lamina propria requires OX40 and CD30 signals.
Withers DR; Jaensson E; Gaspal F; McConnell FM; Eksteen B; Anderson G; Agace WW; Lane PJL
J Immunol; 2009 Oct; 183(8):5079-84. PubMed ID: 19786532
[TBL] [Abstract][Full Text] [Related]
37. OX40 expression enhances the prognostic significance of CD8 positive lymphocyte infiltration in colorectal cancer.
Weixler B; Cremonesi E; Sorge R; Muraro MG; Delko T; Nebiker CA; Däster S; Governa V; Amicarella F; Soysal SD; Kettelhack C; von Holzen UW; Eppenberger-Castori S; Spagnoli GC; Oertli D; Iezzi G; Terracciano L; Tornillo L; Sconocchia G; Droeser RA
Oncotarget; 2015 Nov; 6(35):37588-99. PubMed ID: 26439988
[TBL] [Abstract][Full Text] [Related]
38. CD4⁺ T cells expressing latency-associated peptide and Foxp3 are an activated subgroup of regulatory T cells enriched in patients with colorectal cancer.
Mahalingam J; Lin CY; Chiang JM; Su PJ; Chu YY; Lai HY; Fang JH; Huang CT; Lin YC
PLoS One; 2014; 9(9):e108554. PubMed ID: 25268580
[TBL] [Abstract][Full Text] [Related]
39. FOXP3+ Tregs: heterogeneous phenotypes and conflicting impacts on survival outcomes in patients with colorectal cancer.
Zhuo C; Xu Y; Ying M; Li Q; Huang L; Li D; Cai S; Li B
Immunol Res; 2015 Mar; 61(3):338-47. PubMed ID: 25608795
[TBL] [Abstract][Full Text] [Related]
40. Tumor Infiltrating Regulatory T Cells in Sporadic and Colitis-Associated Colorectal Cancer: The Red Little Riding Hood and the Wolf.
Fantini MC; Favale A; Onali S; Facciotti F
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32937953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
